Woodline Partners reported a 8.3% stake in Sagimet Biosciences SGMT · 2,552,536 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 8.3%
Last report: First report
Shares held: 2,552,536 sh
Class: Series A Common Stock, par value $0.0001 per share
Stock: Sagimet Biosciences SGMT
Holder: Woodline Partners
Event date: 25/06/30
Filed: 25/08/14

First 5%+ report · 8.3% stake

Sagimet Biosciences trades, last 26 weeks

What else happened in Sagimet Biosciences around then

Filed or reported within 30 days of the trade day · 25/05/31~25/07/30

Woodline Partners's other 5% stake reports

Woodline Partners
5% stakeZevra Therapeutics
5% stake
Zevra Therapeutics
ZVRA
8.1% stake
4,785,771 sh
8.1% stake
Filed 08/14
Woodline Partners
5% stakeTango Therapeutics
5% stake
Tango Therapeutics
TNGX
2.5% stake
4,000,567 sh
2.5% stake
Filed 08/14
Woodline Partners
5% stakeSAB Biotherapeutics
5% stake
SAB Biotherapeutics
SABS
6.8% stake
5,455,355 sh
6.8% stake
Filed 08/14
Woodline Partners
5% stakeCervoMed
5% stake
CervoMed
CRVO
5.1% stake
688,987 sh
5.1% stake
Filed 08/14
Woodline Partners
5% stakeCalciMedica
5% stake
CalciMedica
CALC
8.1% stake
2,489,729 sh
8.1% stake
Filed 08/14